Central European Journal of Medicine

, Volume 6, Issue 2, pp 158–162

Serum IGF-1 and IGFBP-3 levels in subclinical hypothyroid women

  • Huriye Balci
  • Tijen Yesim Erdem
  • Serdal Ugurlu
  • Demet Ozgul Yetkin
  • I. Murat Bolayirli
  • Munire Hacibekiroglu
  • Ertugrul Tasan
Research Article

DOI: 10.2478/s11536-010-0036-3

Cite this article as:
Balci, H., Erdem, T.Y., Ugurlu, S. et al. cent.eur.j.med (2011) 6: 158. doi:10.2478/s11536-010-0036-3
  • 76 Downloads

Abstract

Thyroid status is known to influence growth in mammals. The aim of this study is to investigate the possible relationship between autoimmune subclinical hypothyroidism and growth hormone (GH), insulin-like growth factor-1(IGF-1) and insulin-like growth factor binding protein-3(IGFBP-3) levels. Thirty-five women with autoimmune subclinical hypothyroidism, 33 years of age, were used as controls and enrolled in the study. Free triiodothyronin (FT3), free thyroxin(FT4), thyrotropin(TSH), anti-thyroid peroxidase(Anti-TPO), anti-thyroglobuline(Anti-Tg), GH, IGF-1 and IGFBP-3 levels were measured in blood samples and correlations among these parameters were evaluated. We found no significant differences in GH, IGF-1 or IGFBP-3 between patients and controls. In patients and controls, there were no correlations among thyroid hormones and IGF-1 or IGFBP-3 levels, but GH levels were correlated with FT3, FT4 and TSH only in patients’ group. In controls, only IGF-1 and IGFBP-3 levels were correlated. The present study suggests that subclinical hypothyroidism with high TSH and antibody status does not affect IGF-1 and IGFBP-3 levels in adult women. To our knowledge, this is the first study concerning the relationship between autoimmune subclinical hypothyroidism and IGF-1 and IGFBP-3 levels.

Keywords

IGF-1IGFBP-3Autoimmune subclinical hypothyroidism

Copyright information

© © Versita Warsaw and Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Huriye Balci
    • 1
  • Tijen Yesim Erdem
    • 2
  • Serdal Ugurlu
    • 3
  • Demet Ozgul Yetkin
    • 4
  • I. Murat Bolayirli
    • 1
  • Munire Hacibekiroglu
    • 1
  • Ertugrul Tasan
    • 5
  1. 1.Fikret Biyal Central Research Laboratory, Cerrahpasa Medical FacultyIstanbul UniversityIstanbulTurkey
  2. 2.Division of Endocrinology-Metabolism and Diabetes and Department of MedicineHaseki Education and Research HospitalIstanbulTurkey
  3. 3.Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical FacultyIstanbul UniversityIstanbulTurkey
  4. 4.Division of Endocrinology-Metabolism and Diabetes and Department of MedicineGoztepe Education and Research HospitalIstanbulTurkey
  5. 5.Division of Endocrinology-Metabolism and Diabetes and Department of Medicine, Cerrahpasa Medical FacultyIstanbul UniversityIstanbulTurkey